GeneFerm Biotechnology Co (ROCO:1796) Operating Cash Flow per Share : NT$2.44 (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GeneFerm Biotechnology Co Operating Cash Flow per Share?

GeneFerm Biotechnology Co's operating cash flow per share for the three months ended in Jun. 2024 was NT$-0.05. GeneFerm Biotechnology Co's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$2.44.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of GeneFerm Biotechnology Co was -37.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 41.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for GeneFerm Biotechnology Co's Operating Cash Flow per Share or its related term are showing as below:

ROCO:1796' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -60 Med: 17.4 Max: 102.6
Current: 31.3

During the past 11 years, GeneFerm Biotechnology Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 102.60% per year. The lowest was -60.00% per year. And the median was 17.40% per year.

ROCO:1796's 3-Year OCF Growth Rate is ranked better than
78.29% of 797 companies
in the Drug Manufacturers industry
Industry Median: 6.4 vs ROCO:1796: 31.30

GeneFerm Biotechnology Co Operating Cash Flow per Share Historical Data

The historical data trend for GeneFerm Biotechnology Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneFerm Biotechnology Co Operating Cash Flow per Share Chart

GeneFerm Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.35

2.02

2.43

2.88

4.57

GeneFerm Biotechnology Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															2.25	0.96	1.14	0.39	-0.05

Competitive Comparison of GeneFerm Biotechnology Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, GeneFerm Biotechnology Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneFerm Biotechnology Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GeneFerm Biotechnology Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where GeneFerm Biotechnology Co's Price-to-Operating-Cash-Flow falls into.

GeneFerm Biotechnology Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

GeneFerm Biotechnology Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	190.313	/	41.612
	=	4.57

GeneFerm Biotechnology Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	-2	/	40.200
	=	-0.05

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.44

GeneFerm Biotechnology Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of GeneFerm Biotechnology Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneFerm Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GeneFerm Biotechnology Co Ltd (ROCO:1796) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 33, Xingong Road, Xinying District, Tainan, TWN, 74144

Website

http://www.geneferm.com

GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.

GeneFerm Biotechnology Co Headlines

No Headlines